Bank of America Corp. (NYSE:BAC) has decided to resubmit its requested capital actions and certain 2014 Comprehensive Capital Analysis and Review (CCAR) schedules to the Board of Governors of the Federal Reserve System. Monday’s action was disclosed in an SEC Filing and follows the bank’s prior announcement on April 28, 2014, that it would resubmit its 2014 CCAR items. Bank of America Corp (NYSE:BAC) net profit margin is 15.70% and weekly performance is 1.45%. On last trading day company shares ended up $14.72. Analysts mean target price for the company is $17.19. Bank of America Corp (NYSE:BAC) distance from 50-day simple moving average (SMA50) is -8.24%.
BioCryst Pharmaceuticals, Inc (Nasdaq:BCRX) announced preliminary results from its OPuS-1 (Oral ProphylaxiS-1) proof of concept Phase 2a clinical trial of orally-administered BCX4161 in patients with hereditary angioedema (HAE). The trial met the primary efficacy endpoint, several secondary endpoints and all other objectives established for the trial. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shares fell -0.77% in last trading session and ended the day on $9.01. Its return on assets is -77.00%. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) quarterly performance is -22.39%.
On May 16, Shares of Orexigen Therapeutics Inc (NASDAQ:OREX) were the recipient of a large increase in short interest in the month of April. As of April 30th, there was short interest totalling 19,994,022 shares, an increase of 8.8% from the April 15th total of 18,376,599 shares, Analyst RN reports. Currently, 20.2% of the company’s stock are short sold. Based on an average daily volume of 1,999,972 shares, the short-interest ratio is currently 10.0 days. Orexigen Therapeutics, Inc. (NASDAQ:OREX) shares moved up 5.35% in last trading session and was closed at $5.71, while trading in range of $5.36- $5.72. Orexigen Therapeutics, Inc. (NASDAQ:OREX) year to date (YTD) performance is 1.42%.
Zacks upgraded shares of Aruba Networks Inc (NASDAQ:ARUN) from an underperform rating to a neutral rating in a report issued on Friday. They currently have $20.60 target price on the stock. Aruba Networks, Inc. (NASDAQ:ARUN) ended the last trading day at $17.89. Company weekly volatility is calculated as 4.78% and price to cash ratio as 6.86. Aruba Networks, Inc. (NASDAQ:ARUN) showed a negative weekly performance of -6.14%.
Canadian Solar Inc. (NASDAQ:CSIQ) one of the world’s largest solar power companies, today announced that it has entered into an agreement (the “JV Agreement) with GCL-Poly Solar System Integration (China) Co., Ltd., a subsidiary of GCL-Poly Energy Holdings Limited (“GCL”, stock code: 3800.HK) to establish a joint venture (the “Joint Venture”) to build a manufacturing site to produce crystalline silicon solar cells in Funing, Jiangsu Province, China. Under the terms of the agreement, Canadian Solar will own 80% and GCL will own 20% of the equity in the Joint Venture. Canadian Solar Inc. (NASDAQ:CSIQ) net profit margin is 2.10% and weekly performance is 9.65%. On last trading day company shares ended up $24.20. Analysts mean target price for the company is $42.29. Canadian Solar Inc. (NASDAQ:CSIQ) distance from 50-day simple moving average (SMA50) is -16.22%.